Biology Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
WOONSOCKET, R.I., Dec. 26, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual Meeting in San Francisco, CA, on Tuesday, December 18.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 28, 2012 Category: Pharmaceuticals Source Type: clinical trials

Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Pain.
Conditions: Chronic Pain; Depression; PTSD Symptoms; SleepInterventions: Other: Traditional Chinese Acupuncture; Device: Tennant™ Biomodulator Treatment; Device: Transcutaneous electrical nerve stimulation (TENS) TreatmentSponsors: Samueli Institute for Information Biology; Samueli Institute for Information BiologyRecruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2012 Category: Research Source Type: clinical trials

Aduro Announces Two Presentations at Keystone Meeting
BERKELEY, Calif.--(BUSINESS WIRE)--Dec 12, 2012 - Aduro BioTech, Inc. is pleased to announce that Thomas W. Dubensky, Chief Scientific Officer, and Peter Lauer, Director of Molecular Biology, have been selected to deliver oral presentations at... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 12, 2012 Category: Pharmaceuticals Source Type: clinical trials

Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System
PASADENA, Calif.--(BUSINESS WIRE)--Oct 29, 2012 - Arrowhead Research Corporation (NASDAQ:ARWR), a targeted therapeutics company, announced that David Lewis, Ph.D., Vice President Biology and Site Head of its Madison, WI research and development... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 29, 2012 Category: Pharmaceuticals Source Type: clinical trials

Epizyme Publishes Landmark Data on Personalized Therapeutics for Lymphomas
- Unprecedented Demonstration of Selective Killing of Lymphoma Cells with EZH2 Mutation - Published in Nature Chemical Biology - Sheds Light on Biological Understanding of Treatments for Genetically Defined Cancers - CAMBRIDGE, Mass., Oct. 1, 2012... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 1, 2012 Category: Pharmaceuticals Source Type: clinical trials

Vitae Pharmaceuticals Announces Promising Data for VTP-4, Drug Candidate Advancing toward Clinical Testing for the Treatment of Atherosclerosis
Data Presentation at the Frontiers in Lipid Biology conference in Banff, Canada FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Sep 6, 2012 -Vitae Pharmaceuticals, a clinical?stage biopharmaceutical company discovering and developing novel, small... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 6, 2012 Category: Pharmaceuticals Source Type: clinical trials

Texas A&M Biologists Prove ZOLOFT Packs Potential to Fight Fungal Meningitis
COLLEGE STATION, Texas, July 25, 2012 /PRNewswire-USNewswire/ -- New research conducted by biologists at Texas A&M University suggests that ZOLOFT®, one of the most widely prescribed antidepressants in the world, also packs... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 25, 2012 Category: Pharmaceuticals Source Type: clinical trials

Neuroblastoma Biology Study
Condition: NeuroblastomaIntervention: Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy ConsortiumRecruiting - verified April 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2012 Category: Research Source Type: clinical trials

Neuroblastoma Biology Study
Condition: NeuroblastomaIntervention: Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy ConsortiumRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2012 Category: Research Source Type: clinical trials

Neuroblastoma Biology Study
Condition: NeuroblastomaIntervention: Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy ConsortiumRecruiting - verified April 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2012 Category: Research Source Type: clinical trials

Neuroblastoma Biology Study
Condition: NeuroblastomaIntervention: Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy ConsortiumRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2012 Category: Research Source Type: clinical trials

Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)
Condition: Pulmonary TuberculosisInterventions: Drug: Active Sodium Phenylbutyrate and active cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus active cholecalciferol; Drug: Active Sodium Phenylbutyrate and placebo cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus placebo cholecalciferolSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; International Centre for Diarrhoeal Disease Research, Bangladesh; Dept. of medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; National Tuberculosis Reference Laboratory, National Institute of Di...
Source: ClinicalTrials.gov - April 18, 2012 Category: Research Source Type: clinical trials

Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)
Condition: Pulmonary TuberculosisInterventions: Drug: Active Sodium Phenylbutyrate and active cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus active cholecalciferol; Drug: Active Sodium Phenylbutyrate and placebo cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus placebo cholecalciferolSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; International Centre for Diarrhoeal Disease Research, Bangladesh; Dept. of medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; National Tuberculosis Reference Laboratory, National Institute of Di...
Source: ClinicalTrials.gov - April 17, 2012 Category: Research Source Type: clinical trials